Efavirenz Causes Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Endothelial Cells

Regulation of Autophagy in Oxygen-Dependent Cellular Stress

(2013) Stefan W. Ryter et al.   CURRENT PHARMACEUTICAL DESIGN

ER stress in human hepatic cells treated with Efavirenz: Mitochondria again

(2013) Nadezda Apostolova et al.   JOURNAL OF HEPATOLOGY

Profile of stress and toxicity gene expression in human hepatic cells treated with Efavirenz

(2012) Leysa J. Gomez-Sucerquia et al.   ANTIVIRAL RESEARCH

Renal Toxicity Associated With Antiretroviral Therapy

(2012) Leonardo Calza   HIV CLINICAL TRIALS

Reactive Oxygen Species in Health and Disease

(2012) Assim A. Alfadda et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study

(2012) Samir K. Gupta et al.   PLoS One

Endothelial and platelet function alterations in HIV-infected patients

(2011) P. Gresele et al.   THROMBOSIS RESEARCH

Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes

(2011) Namandjé N. Bumpus   TOXICOLOGY AND APPLIED PHARMACOLOGY

Influence of antiretroviral therapy on liver disease

(2011) Helen Kovari et al.   Current Opinion in HIV and AIDS

New Prospects for Nelfinavir in Non-HIV-Related Diseases

(2010) Ansgar Bruning et al.   Current Molecular Pharmacology

The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art

(2009) Irina Arnaoutova et al.   ANGIOGENESIS

Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cells

(2009) Md Saha Jamaluddin et al.   ATHEROSCLEROSIS

A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line

(2009) EVELYN ARANDA et al.   BIOLOGICAL RESEARCH

Efavirenz in the therapy of HIV infection

(2009) Natella Y Rakhmanina et al.   Expert Opinion on Drug Metabolism & Toxicology

Efavirenz: a decade of clinical experience in the treatment of HIV

(2009) F. Maggiolo   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efavirenz – Still First-line King?

(2008) Brookie M Best et al.   Expert Opinion on Drug Metabolism & Toxicology